Please assess the completion status of the following clinical trial:

Trial Title: Adenosine Cardioplegia; Improved Cardioprotection?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective patients~* Ejection fraction \> 40%~* Age 40-75~* No release og TnT or CKMB within last week before CABG~* Pure CABG~Exclusion Criteria:~* Age \>75 or \< 40~* EF \< 40%~* Emergency operations~* Unstable angina~* Release of TnT or CKMB within the week before operation

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Adenosine cardioplegia (Type: EXPERIMENTAL): Adenosine cardioplegia
- Control (Type: ACTIVE_COMPARATOR): Standard hyperkalemic cardioplegia

Based on this trial design, predict the completion outcome and termination type (if applicable).